Global Artificial Intelligence in Oncology Market Size to Hit USD 2,145.1 Million by 2025, grow at a CAGR of 33.7%
Global Artificial Intelligence in Oncology Market Key Takeaways
According to Coherent Market Insights (CMI), the global artificial intelligence in oncology market size is expected to grow more than 7.6X, from USD 2,145.1 Mn in 2025 to USD 16,382 Mn by 2032, exhibiting a robust CAGR of 33.7%.
Based on component, software/platform segment is anticipated to account for a prominent market share of 64.2% in 2025.
North America is expected to retain its dominance, accounting for more than one-third of the global artificial intelligence in oncology market share in 2025.
Europe is projected to remain the second-leading market for AI-powered oncology companies.
As per Coherent Market Insights' new global artificial intelligence in oncology market analysis, Asia Pacific is poised to witness fastest growth throughout the assessment period.
Increasing Cancer Prevalence Spurring Market Growth
Coherent Market Insights' latest global artificial intelligence in oncology market research report highlights key factors driving market growth. One such prominent growth factor is the rising incidence of cancer.
The IARC's Global Cancer Observatory projects that annual new cancer cases will surpass 35 million by 2050. This sharp rise in cancer incidence is anticipated to drive demand for artificial intelligence in oncology.
Artificial intelligence is revolutionizing oncology by enhancing cancer detection, treatment planning, and drug discovery. Therefore, growing cancer burden is poised to play a crucial role in driving adoption of AI-based oncology solutions over the forecast period.
High Implementation Costs and Data Privacy Concerns Restraining Market Growth
The global artificial intelligence in oncology market outlook indicates strong future growth. However, high implementation costs and data security concerns are limiting market growth to some extent.
Integrating AI technologies into oncology workflows requires significant investment in hardware and software. This deters small and mid-sized healthcare companies from opting for these technologies, thereby reducing global artificial intelligence in oncology market demand.
AI systems require access to large amounts of patient data, raising concerns about cybersecurity risks as well as potential misuse. This may also negatively impact the global artificial intelligence in oncology market growth during the projection period.
Get Instant Access! Purchase Research Report and Receive a 25% Discount: https://www.coherentmarketinsights.com/insight/buy-now/6509
Technological Advancements in AI Creating New Growth Prospects for the Market
Ongoing innovations in deep learning, computer vision, and natural language processing (NLP) are significantly enhancing AI applications in image analysis, drug discovery, and prognosis prediction. Such breakthroughs are expected to unlock new revenue-generation streams for industry players.
Advanced AI technologies are being increasingly integrated with imaging modalities like MRI and PET scans. This integration enables automated detection of anomalies, enhances diagnostic accuracy, and reduces human error.
Emerging Global Artificial Intelligence in Oncology Market Trends
Rising demand for precision medicine is a key growth-shaping trend in the market. Precision oncology requires analyzing large datasets, including genomics and biomarkers. This is where AI steps in, processing huge data and enabling creation of individualized therapies.
Expanding use of artificial intelligence in radiology and pathology is expected to boost the market. AI technologies are being increasingly used for tumor detection, segmentation, and classification through radiological and histopathological images. This is due to their ability to improve speed and consistency as well as reduce diagnostic errors.
Increasing adoption of AI in drug discovery and development is positively impacting the global artificial intelligence in oncology market value. This advanced technology is revolutionizing drug discovery by rapidly analyzing large datasets to identify potential drug candidates as well as predict their efficacy and toxicity.
Growing adoption of cloud-based AI solutions is significantly contributing to the expansion of the global artificial intelligence in oncology market. These solutions are increasingly favored for their cost-efficiency, scalability, and ability to provide seamless remote access to data and tools.
Analyst's View
' The global artificial intelligence in oncology market is set for rapid expansion, owing to growing prevalence of cancer, rising adoption of precision medicine, and technological advancements in AI technologies,' said senior analyst Komal Dighe.
Current Events and Their Impact on the Global Artificial Intelligence in Oncology Market
Event
Description and Impact
FDA Clears First GenAI-Powered Diagnostic Tool for Breast Cancer Detection (2025)
Description: The U.S. FDA approved a GenAI-based diagnostic platform by PathIntel, capable of identifying breast cancer subtypes with high accuracy using real-world data.
Impact: Such approvals signal growing regulatory acceptance of generative AI in oncology.
Tempus Collaborated with Boehringer to Accelerate AI Usage in Oncology
Description: In May 2025, Tempus entered a multi-year strategic collaboration with Boehringer Ingelheim to apply its AI-driven oncology insights toward cancer‑focused therapeutic discovery and biomarker development
Impact: This will likely boost growth of the AI in oncology market.
Japan's MHLW Updates Reimbursement Guidelines for AI Diagnostics
Description: Japanese Ministry of Health, Labour and Welfare (MHLW) has approved reimbursement for certain AI-enhanced imaging diagnostics
Impact: Such initiatives will increase commercial viability and adoption of AI oncology tools in Asia-Pacific, spurring more localized R&D and product launches.
Competitor Insights
Key companies listed in the global artificial intelligence in oncology market report:
- IBM Corporation
- Intel Corporation
- Azra AI
- NVIDIA Corporation
- Siemens Healthineers AG
- GE HealthCare
- Digital Diagnostics Inc.
- ConcertAI
- PathAI
- Median Technologies
- Microsoft
- Babylon
- Zebra Medical Vision
Key Developments
In June 2025, Viz.ai launched a new strategic alliance with Novartis to accelerate timely diagnosis and deliver AI-powered precision care for cancer patients. Through this collaboration, Viz.ai will focus on developing AI-powered workflows for breast and prostate cancer.
In November 2024, PathAI unveiled PathExplore Fibrosis. This new AI-powered tool is designed to revolutionize collagen, fibrosis, and fiber quantification directly from whole-slide images.
In January 2024, PathAI launched six additional oncology indications for PathExplore, expanding the AI-driven pathology panel to cover ovarian, bladder, liver, small cell lung, lymphoma, and head & neck cancers.
Global Artificial Intelligence in Oncology Market Segmentation:
By Component
Software/Platform
Hardware
Services
By Cancer Type
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
By Treatment Type
Chemotherapy
Radiotherapy
Immunotherapy
Others
By End User:
Hospitals & Clinics
Diagnostic Centers
Biopharmaceutical Companies
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
15 minutes ago
- Globe and Mail
UFP Industries to Report Second Quarter 2025 Results on Monday, July 28, 2025
UFP Industries (Nasdaq: UFPI) will announce second quarter 2025 results after the market close on Monday, July 28, 2025. The company will host a conference call to discuss these results on Tuesday, July 29, 2025, at 9 a.m. Eastern Time. A live audio webcast of the call along with supporting materials will be available on the UFP Industries Investor Relations website at and can also be directly by accessing the link here. A webcast replay will be available on the company's website for at least 90 days following the call. UFP Industries, Inc. UFP Industries, Inc. is a holding company whose operating subsidiaries – UFP Packaging, UFP Construction and UFP Retail Solutions – manufacture, distribute and sell a wide variety of value-added products used in residential and commercial construction, packaging and other industrial applications worldwide. Founded in 1955, the company is headquartered in Grand Rapids, Mich., with affiliates in North America, Europe, Asia and Australia. UFP Industries is ranked #128 on Industry Week's list of America's Largest Manufacturers. For more about UFP Industries, go to
CTV News
15 minutes ago
- CTV News
Latest agriculture technology on display in Sask. farm show
Watch WATCH: As western Canada's largest farm show continues, visitors from far and wide are looking for the latest and greatest in agriculture technology.
CTV News
20 minutes ago
- CTV News
Executive Committee backs plan to install priority transit lanes on Bathurst and Dufferin streets south of Bloor
Toronto Mayor Olivia Chow's Executive Committee has approved a scaled-down plan to install priority transit lanes on Bathurst and Dufferin streets. The plan, which is part of the city's RapidTO network, would see transit lanes installed south of Bloor Street West on Bathurst and Dufferin Streets ahead of the FIFA World Cup next year. In the initial plan, priority lanes for buses or streetcars were also proposed north of Bloor to Eglinton Avenue West on Bathurst Street and to Wilson Avenue on Dufferin Street. But staff has said 'further consideration' of that section 'is proposed to be undertaken at a future time.' The changes came amid pushback from retailers along a stretch of Bathurst Street in The Annex, who said they would be negatively affected by the bus lanes, which may result in some businesses closing. Transit advocates, meanwhile, expressed disappointment over the watered-down plan, especially since staff did not indicate a specific timeline for when transit lanes north of Bloor on those two major roads would be implemented. As a result, during Wednesday's Executive Committee meeting, Mayor Olivia Chow introduced a motion asking city staff to work with her, local councillors, residents, businesses, and transit riders to develop implementation plans for bus lanes on Bathurst Street from Bloor to Eglinton Avenue and on Dufferin Street from Bloor to Wilson Avenue. Her motion also directs staff to report back on interim priority measures that can be implemented for the World Cup, including rush hour prohibitions, time-of-day use, loading zones, and HOV lanes. Ahead of the meeting, Mayor Chow said the RapidTO plans have been around since 2019 and 'it's time to take action,' voicing her support for the plan south of Bloor. 'Nothing has as large an impact as better public transit. The better way to tackle congestion is making sure there's a reliable and faster TTC service, so people take more transit than driving,' the mayor said. Chow added that the city could do better; thus, she wants staff to explore options for improving services north of Bloor ahead of the World Cup, while plans for priority transit lanes along that stretch are stalled. 'I want options,' the mayor said. 'A proper implementation of RapidTO means thousands of new riders on TTC. Less frustration.' Transit advocacy group TTCRiders celebrated the Executive Committee's approval of the transit lanes, saying, 'This is a win for transit riders.' The group also welcomed Chow's motion. 'We're pleased that Mayor Chow's amendment (commits) to clear timelines extending these lanes further north, fulfilling commitments made by her and other members of the Executive,' TTCRiders Executive Director Andrew Pulsifer said in a news release. Last year, council directed staff to accelerate RapidTO projects on Dufferin and Bathurst streets for the upcoming FIFA World Cup. The city said construction for the transit lanes would begin in the fall and is expected to be finished before the start of the World Cup. According to the report, the implementation of the transit priority lanes on Dufferin and Bathurst is expected to cost $8 million. The plan now goes before city council for final approval.
